Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT

S. Adam Strickberger; John D. Hummel; Thomas G. Bartlett; Howard Frumin; Claudio Schuger; Scott L. Beau; Cynthia Bitar; Fred Morady

doi:10.1016/s0735-1097(03)00297-3

Keywords

MedicineAmiodaroneVentricular tachycardiaCardiologyInternal medicineImplantable cardioverter-defibrillatorEjection fractionRandomized controlled trialClinical endpointAsymptomaticCardiomyopathyHeart failureAtrial fibrillation

Affiliated Institutions

Related Publications

A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias

The Antiarrhythmics versus Implantable Defibrillators Investigators

Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter-defibrillator is superior to antiarrhythmi...

1997 New England Journal of Medicine 3203 citations

Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia

Steven L. Higgins , Helmut Klein , Joseph Levine +9 more

In patients with a prior myocardial infarction who are at high risk for ventricular tachyarrhythmia, prophylactic therapy with an implanted defibrillator leads to improved survi...

1996 New England Journal of Medicine 4139 citations

Dual-Chamber Pacing or Ventricular Backup Pacing in Patients With an Implantable Defibrillator

Bruce L. Wilkoff , James R. Cook , Andrew E. Epstein +5 more

For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber pacing offers no clinical advantage over ventr...

2002 JAMA 2014 citations

Canadian Implantable Defibrillator Study (CIDS)

Stuart J. Connolly , Michael Gent , Robin S. Roberts +7 more

Background —Patients surviving ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The implant...

2000 Circulation 1589 citations

Initial Clinical Experience with a New Small Sized Third‐Generation Implantable Cardioverter Defibrillator: Results of a Multicenter Study

Guilherme Fenelon , Etienne Huvelle , Pedro Brugada

This study reports the acute clinical experience with the new CPI VENTAK MINI: a small sized (68 cc), implantable cardioverter defibrillator (ICD) with 33 J stored energy. Impla...

1997 Pacing and Clinical Electrophysiology 11 citations

Publication Info

Year: 2003
Type: article
Volume: 41
Issue: 10
Pages: 1707-1712
Citations: 578
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

578

OpenAlex

Cite This

APA Style

                            
                                
                                    S. Adam Strickberger, 
                                
                                    John D. Hummel, 
                                
                                    Thomas G. Bartlett
                                
                                et al.
                            
                            (2003). 
                            Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemicdilated cardiomyopathy and asymptomaticnonsustained ventricular tachycardia—AMIOVIRT. 
                            Journal of the American College of Cardiology
                            , 41
                            (10)
                            , 1707-1712.
                            https://doi.org/10.1016/s0735-1097(03)00297-3
                        

Identifiers

DOI: 10.1016/s0735-1097(03)00297-3